HGLB vs HQL

Highland Global Allocation Fund vs TeklaLife Sciences Investors — Valuation Comparison 2026

HGLB

Asset Management
Highland Global Allocation Fund
Quality
1.7
out of 10
Value Trap
Price
$8.11
Last close
Models
6/13
Active
VS

HQL

Asset Management
TeklaLife Sciences Investors
Quality
1.9
out of 10
Value Trap
Price
$17.67
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType HGLB Fair ValueHGLB Upside HQL Fair ValueHQL Upside
Bayesian DCF Intrinsic $2.15 -73.5% $4.68 -73.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
Markov DDM Intrinsic $9.16 +12.3% $71.50 +307.4%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for HGLB vs HQL — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HGLB vs HQL — Which Stock Is More Undervalued?

HQL scores higher with a 1.9/10 quality rating vs HGLB's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Highland Global Allocation Fund (HGLB) and TeklaLife Sciences Investors (HQL) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HGLB currently trades at $8.11 with a QOC of 1.7/10, while HQL trades at $17.67 with a QOC of 1.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).